Patrick Trojer

Patrick Trojer, PhD, is the President and CEO of TRIANA Biomedicines, Inc., where they lead a groundbreaking biotechnology company focused on molecular glue discovery for challenging disease targets. Previously, they held multiple senior positions at Constellation Pharmaceuticals, ultimately serving as Senior Vice President of Translational Research & EZH2 Franchise Executive. Patrick's extensive background in research also includes a postdoctoral fellowship at New York University and various advisory roles at organizations such as RA Capital Management, L.P. and BiOrigin. They earned their MS and Ph.D. in Biochemistry and Molecular Biology from Leopold-Franzens Universität Innsbruck.